BWP
CVS icon

Baldwin Wealth Partners’s CVS Health CVS Stock Holding History

Baldwin Wealth Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,652
Closed -$247K – 224
2025
Q1 		$247K Buy
+3,652
New +$219K 0.02% 196
2024
Q4 		– Sell
-7,671
Closed -$482K – 416
2024
Q3 		$482K Sell
7,671
-881
-10% -$51.4K 0.03% 202
2024
Q2 		$505K Sell
8,552
-1,894
-18% -$118K 0.04% 143
2024
Q1 		$833K Sell
10,446
-38
-0.4% -$2.9K 0.06% 113
2023
Q4 		$828K Buy
10,484
+336
+3% +$23.9K 0.07% 109
2023
Q3 		$709K Sell
10,148
-4,625
-31% -$328K 0.06% 123
2023
Q2 		$1.02M Sell
14,773
-10
-0.1% -$712 0.08% 110
2023
Q1 		$1.1M Buy
14,783
+580
+4% +$48.6K 0.1% 109
2022
Q4 		$1.32M Buy
14,203
+2,024
+17% +$195K 0.12% 105
2022
Q3 		$1.16M Sell
12,179
-5,100
-30% -$505K 0.16% 63
2022
Q2 		$1.6M Hold
17,279
– – 0.21% 59
2022
Q1 		$1.75M Buy
17,279
+1,500
+10% +$158K 0.19% 61
2021
Q4 		$1.63M Hold
15,779
– – 0.16% 63
2021
Q3 		$1.34M Buy
15,779
+5,955
+61% +$499K 0.15% 65
2021
Q2 		$820K Hold
9,824
– – 0.09% 81
2021
Q1 		$739K Sell
9,824
-587
-6% -$42.8K 0.09% 79
2020
Q4 		$711K Sell
10,411
-1,200
-10% -$78.1K 0.09% 84
2020
Q3 		$678K Hold
11,611
– – 0.09% 87
2020
Q2 		$755K Hold
11,611
– – 0.11% 82
2020
Q1 		$689K Sell
11,611
-3,500
-23% -$234K 0.12% 82
2019
Q4 		$1.12M Buy
15,111
+200
+1% +$14K 0.16% 75
2019
Q3 		$941K Buy
14,911
+165
+1% +$9.78K 0.14% 81
2019
Q2 		$803K Buy
14,746
+257
+2% +$13.8K 0.12% 93
2019
Q1 		$782K Buy
14,489
+3,251
+29% +$201K 0.12% 99
2018
Q4 		$736K Buy
11,238
+104
+0.9% +$7.76K 0.12% 93
2018
Q3 		$877K Buy
11,134
+3,273
+42% +$234K 0.12% 98
2018
Q2 		$506K Buy
7,861
+4,750
+153% +$313K 0.08% 125
2018
Q1 		$194K Buy
3,111
+200
+7% +$14.3K 0.03% 197
2017
Q4 		$211K Hold
2,911
– – 0.03% 190
2017
Q3 		$237K Sell
2,911
-1,225
-30% -$96.9K 0.04% 179
2017
Q2 		$333K Sell
4,136
-2,975
-42% -$235K 0.05% 160
2017
Q1 		$558K Sell
7,111
-1,275
-15% -$102K 0.09% 118
2016
Q4 		$662K Sell
8,386
-467
-5% -$37.8K 0.12% 107
2016
Q3 		$788K Sell
8,853
-2,522
-22% -$238K 0.14% 88
2016
Q2 		$1.09M Sell
11,375
-9,180
-45% -$915K 0.22% 69
2016
Q1 		$2.13M Sell
20,555
-12,006
-37% -$1.17M 0.38% 59
2015
Q4 		$3.18M Sell
32,561
-3,444
-10% -$337K 0.52% 52
2015
Q3 		$3.47M Sell
36,005
-64
-0.2% -$6.73K 0.59% 50
2015
Q2 		$3.78M Buy
36,069
+1,160
+3% +$119K 0.56% 50
2015
Q1 		$3.6M Buy
34,909
+74
+0.2% +$7.49K 0.53% 52
2014
Q4 		$3.35M Sell
34,835
-914
-3% -$80.5K 0.49% 56
2014
Q3 		$2.85M Buy
35,749
+792
+2% +$62.4K 0.4% 63
2014
Q2 		$2.63M Buy
34,957
+395
+1% +$29.9K 0.39% 63
2014
Q1 		$2.59M Buy
34,562
+20,274
+142% +$1.43M 0.42% 59
2013
Q4 		$1.02M Buy
14,288
+3,800
+36% +$244K 0.16% 128
2013
Q3 		$595K Sell
10,488
-30
-0.3% -$1.79K 0.11% 150
2013
Q2 		$601K Buy
+10,518
New +$609K 0.12% 137

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baldwin Wealth Partners's CVS Position: Q2 2025 in Review

Baldwin Wealth Partners sold out of CVS Health (CVS) in Q2 2025, closing a stake of 3,652 shares — an estimated $247K sold.

Baldwin Wealth Partners first reported a position in CVS in Q2 2013 and held it in 47 quarters. The position peaked at $3.78M in Q2 2015. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Baldwin Wealth Partners reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Baldwin Wealth Partners sold 3,652 CVS Health shares in Q2 2025, an estimated $247K.
  • Baldwin Wealth Partners first reported a position in CVS Health in Q2 2013 and held it in 47 quarters.
  • Baldwin Wealth Partners's CVS Health position peaked at $3.78M in Q2 2015.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Baldwin Wealth Partners's 13F filing for Q2 2025, filed 24 Jul 2025.